Abstract
The population of survivors with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC) is rising. The improved prognosis of this etiologic subset is reflected in new staging guidelines as well as ongoing deintensification trials aiming to preserve excellent survival while decreasing treatment-related toxicities. However, as staging criteria and treatment standards evolve in the era of transoral surgery and deintensification, little is known regarding the needs and treatment preferences of patients with HPV-OPSCC. Herein, the current knowledge regarding treatment preferences and priorities, quality of life and concerns among patients with HPV-OPSCC is reviewed.
| Original language | English |
|---|---|
| Pages (from-to) | 2521-2530 |
| Number of pages | 10 |
| Journal | Future Oncology |
| Volume | 14 |
| Issue number | 24 |
| DOIs | |
| State | Published - Oct 2018 |
Bibliographical note
Publisher Copyright:© 2018 Future Medicine Ltd.
Keywords
- Head and neck cancer
- Human papillomavirus
- Oropharyngeal cancer
- Otolaryngology
- Patient preference
- Radiotherapy
- Robotic surgical procedures
- Shared decision-making
ASJC Scopus subject areas
- Oncology
- Cancer Research
